Literature DB >> 3385443

Thymectomy in the treatment of myasthenia gravis: report of 247 patients.

A Evoli1, A P Batocchi, C Provenzano, E Ricci, P Tonali.   

Abstract

We made a retrospective assessment of the long-term outcome in 247 consecutive patients with myasthenia gravis (MG) who underwent thymectomy in the period January 1971-December 1985. In 84 cases a thymoma was found at surgery, while 163 patients had a non-neoplastic thymus. The duration of symptoms before surgery, the age at onset of the disease and the presence of germinal centres in the thymus did not appear to influence the prognosis. Patients with a non-neoplastic thymus showed a better response to thymectomy. Thymoma was associated with more severe disease and with a higher mortality; moreover, more thymoma patients required corticosteroid treatment in order to achieve good therapeutic results. In our opinion, thymectomy is indicated in the treatment of generalized MG, while ocular myasthenia seems not to be improved by the removal of the thymus.

Entities:  

Mesh:

Year:  1988        PMID: 3385443     DOI: 10.1007/bf00314173

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations.

Authors:  G Genkins; A E Papatestas; S H Horowitz; P Kornfield
Journal:  Am J Med       Date:  1975-04       Impact factor: 4.965

2.  Sex and age in myasthenia gravis as critical factors in incidence and remission.

Authors:  R S SCHWAB; C C LELAND
Journal:  J Am Med Assoc       Date:  1953-12-05

Review 3.  Thymectomy in myasthenia gravis: pathologic, clinical, and electrophysiologic correlations.

Authors:  A E Papatestas; G Genkins; S H Horowitz; P Kornfeld
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

4.  [Surgical treatment of myasthenia by thymectomy. A report on 248 cases (author's transl)].

Authors:  H Le Brigand; P Levasseur; A R Miranda; C Gaud; I Wojakowski
Journal:  Ann Chir       Date:  1980-03

Review 5.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

6.  Myasthenia gravis and invasive thymoma: a 20-year experience.

Authors:  A J Goldman; C Herrmann; J C Keesey; D G Mulder; W J Brown
Journal:  Neurology       Date:  1975-11       Impact factor: 9.910

7.  The value of thymectomy in myasthenia gravis: a computer-assisted matched study.

Authors:  J M Buckingham; F M Howard; P E Bernatz; W S Payne; E G Harrison; P C O'Brien; L H Weiland
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

8.  Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.

Authors:  E Bartoccioni; F Scuderi; C Scoppetta; A Evoli; P Tonali; L Guidi; C Bartoloni; T Terranova
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

9.  Thymectomy for myasthenia gravis: 14-year experience.

Authors:  J R Hankins; R F Mayer; J R Satterfield; S Z Turney; S Attar; A J Sequeira; B W Thompson; J S McLaughlin
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

10.  Thymectomy in myasthenia with pure ocular symptoms.

Authors:  F Schumm; H Wiethölter; A Fateh-Moghadam; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

View more
  9 in total

1.  Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.

Authors:  C W Zimmermann; F Eblen
Journal:  Clin Investig       Date:  1993-06

2.  Mortality and survival in myasthenia gravis: a Danish population based study.

Authors:  P B Christensen; T S Jensen; I Tsiropoulos; T Sørensen; M Kjaer; E Højer-Pedersen; M J Rasmussen; E Lehfeldt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

Review 3.  Long-term outcome and quality of life after thymectomy for myasthenia gravis.

Authors:  C Busch; A Machens; U Pichlmeier; T Emskötter; J R Izbicki
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

4.  Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.

Authors:  Huanhuan Li; Zhe Ruan; Feng Gao; Hongyu Zhou; Rongjing Guo; Chao Sun; Quan Xu; Qiang Lu; Yongan Zhou; Zhengwei Zhao; Liping Yu; Songdi Wu; Tao Lei; Ting Gao; Yonglan Tang; Chunhong Li; Feiyan Huo; Ying Zhu; Jie Sun; Baoli Tang; Min Zhang; Yanwu Gao; Xiaodan Lu; Zhuyi Li; Ting Chang
Journal:  Neurotherapeutics       Date:  2021-10-08       Impact factor: 6.088

5.  Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients.

Authors:  Kai Bachmann; Doreen Burkhardt; Inken Schreiter; Jussuf Kaifi; Christoph Busch; Gunther Thayssen; Jakob R Izbicki; Tim Strate
Journal:  Surg Endosc       Date:  2008-02-23       Impact factor: 4.584

6.  Microscopic thymoma and myasthenia gravis.

Authors:  F Puglisi; N Finato; L Mariuzzi; C Marchini; G Floretti; C A Beltrami
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

Review 7.  Ocular myasthenia gravis: a review.

Authors:  Akshay Gopinathan Nair; Preeti Patil-Chhablani; Devendra V Venkatramani; Rashmin Anilkumar Gandhi
Journal:  Indian J Ophthalmol       Date:  2014-10       Impact factor: 1.848

Review 8.  Controversies in Ocular Myasthenia Gravis.

Authors:  Amelia Evoli; Raffaele Iorio
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

Review 9.  International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.

Authors:  Pushpa Narayanaswami; Donald B Sanders; Gil Wolfe; Michael Benatar; Gabriel Cea; Amelia Evoli; Nils Erik Gilhus; Isabel Illa; Nancy L Kuntz; Janice Massey; Arthur Melms; Hiroyuki Murai; Michael Nicolle; Jacqueline Palace; David Richman; Jan Verschuuren
Journal:  Neurology       Date:  2020-11-03       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.